Treatment with the IGF-1–derived tripeptide (1–3) IGF-1 rescues interneuron connectivity, normalizes inhibitory synapses, abolishes spasms, and reverses hypsarrhythmia-like EEG abnormalities in most treated animals [204]. The gene discussed is IGF1; the disease is Hypsarrhythmia.